BEDFORD, Mass., — Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the fourth fiscal quarter and fiscal year ended September 29, 2012. Highlights of the Quarter […]
Corning Incorporated (NYSE:GLW) announced today that, pursuant to its previously announced cash tender offer, $74,681,000 million in aggregate principal amount of debentures subject to the cash tender offer were validly tendered and not validly withdrawn before 5 p.m. New York City time on Thursday, Nov. 8, 2012, the Early Tender Date for the tender offer, […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized an increase of its quarterly cash dividend from $0.13 to $0.15 per common share, payable on January 15, 2013, to shareholders of record as of December 17, 2012. The board also […]
SAN DIEGO, Nov. — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported revenue of $22.9 million for the third quarter of 2012, an increase of 25% from revenue of $18.3 million in the second quarter of 2012 and a 68% increase compared to revenue of $13.6 million for […]
WALTHAM, Mass.– Repligen Corporation (NASDAQ: RGEN) today reported financial results for its third quarter and year-to-date period ended September 30, 2012. The Company reported net income for the three-month period ended September 30, 2012 of $1,806,000 or $0.06 per diluted share, compared to $605,000 or $0.02 per diluted share for the same period in 2011, […]
SOUTH SAN FRANCISCO, Calif. –– Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2012. Product revenue for the third quarter of 2012 was $12.6 million, an increase of 24% from $10.2 million in the third quarter of 2011. Product margin was a record 72% in the third quarter […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.967 billion for the fourth fiscal quarter ended September 30, 2012, representing a decrease of 1.1 percent from the prioryear period, or an increase of 4.7 percent on a foreign currency-neutral basis. For […]
Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial results today for the third quarter ended September 30, 2012. Third-quarter reported revenues were $498.7 million, a decrease of 3.5% compared to $516.5 million reported for the third quarter of […]
BILLERICA, Mass.– Bruker Corporation (NASDAQ: BRKR) today reported financial results for the third quarter ended September 30, 2012. Bruker Corporation Financial Results In the third quarter of 2012, revenue was $447.8 million, an increase of 7.0% compared to $418.4 million in the third quarter of 2011. Excluding the effects of acquisitions and foreign currency translation, […]
SANTA CLARA, Calif.—- Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2012. Total revenue for the quarter was $79.6 million, including approximately $17.6 million in revenue from eBioscience during the third quarter of 2012. This compares to total revenue of $64.0 million for the same period of 2011. The […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
